Literature DB >> 9083596

How important is publication bias? A synthesis of available data.

K Dickersin1.   

Abstract

It has long been recognized that investigators frequently fail to report their research findings (Dickersin, 1990). Chalmers (1990) has suggested that this failure represents scientific misconduct since volunteers who consent to participate in research, and agencies that provide funding support for investigations, do so with the understanding that the work will make a contribution to knowledge. Clearly, knowledge that is not disseminated is not making a "contribution". This failure to publish is not only inappropriate scientific conduct, it also influences the information available for interpretation by the scientific community. Of course, if research is left randomly unpublished, there is less information available, but that information is unbiased. We now have solid evidence that failure to publish is not a random event; rather, publication is dramatically influenced by the direction and strength of research findings (Dickersin et al., 1987, 1992; Dickersin & Min, 1993; Easterbrook et al., 1991; Simes, 1986). This tendency of editors and reviewers to accept manuscripts submitted by investigators based on the strength and direction of the research findings is termed "publication bias". The problem has been under discussion for many years and has recently been studied directly in medicine and public health. This article will review the major evidence available regarding publication bias and will suggest measures for overcoming the problem.

Mesh:

Year:  1997        PMID: 9083596

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  58 in total

1.  Evaluating treatment effects reliably.

Authors:  Martin J Landray; Gary Whitlock
Journal:  BMJ       Date:  2002-12-14

Review 2.  Evaluating drug treatments for Parkinson's disease: how good are the trials?

Authors:  Keith Wheatley; Rebecca L Stowe; Carl E Clarke; Robert K Hills; Adrian C Williams; Richard Gray
Journal:  BMJ       Date:  2002-06-22

Review 3.  Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Authors:  Hans Melander; Jane Ahlqvist-Rastad; Gertie Meijer; Björn Beermann
Journal:  BMJ       Date:  2003-05-31

4.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

Authors:  An-Wen Chan; Karmela Krleza-Jerić; Isabelle Schmid; Douglas G Altman
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

5.  Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

Authors:  Kay Dickersin; Iain Chalmers
Journal:  J R Soc Med       Date:  2011-12       Impact factor: 5.344

6.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

7.  Evaluation of new treatments in radiation oncology: are they better than standard treatments?

Authors:  Heloisa P Soares; Ambuj Kumar; Stephanie Daniels; Suzanne Swann; Alan Cantor; Iztok Hozo; Mike Clark; Fadila Serdarevic; Clement Gwede; Andy Trotti; Benjamin Djulbegovic
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

8.  Trauma care research and the war on uncertainty.

Authors:  Ian Roberts; Haleema Shakur; Phil Edwards; David Yates; Peter Sandercock
Journal:  BMJ       Date:  2005-11-12

9.  Finding studies for inclusion in systematic reviews of interventions for injury prevention the importance of grey and unpublished literature.

Authors:  K Blackhall
Journal:  Inj Prev       Date:  2007-10       Impact factor: 2.399

Review 10.  Social capital and health care access: a systematic review.

Authors:  Kathryn Pitkin Derose; Danielle M Varda
Journal:  Med Care Res Rev       Date:  2009-01-27       Impact factor: 3.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.